<DOC>
	<DOC>NCT00141180</DOC>
	<brief_summary>To evaluate the suitability of contact allergy as a method for the evaluation of c-chemokine receptor-1 antagonist.</brief_summary>
	<brief_title>CP-481,715 Nickel Allergy Study.</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Allergic Contact</mesh_term>
	<mesh_term>Nickel</mesh_term>
	<criteria>A history of nickel allergy confirmed by a visual positive reaction (graded at least ++) to T.R.U.E. TEST. Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding contact allergic dermatitis or untreated, asymptomatic, seasonal allergies at time of dosing).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>